Predictive toxicology is a pivotal branch of pharmacology that employs advanced scientific techniques to anticipate and assess potential adverse effects of chemical compounds on living organisms. By leveraging computational models, bioinformatics, and high-throughput screening methods, predictive toxicology aims to streamline drug development processes and enhance safety assessments. This interdisciplinary approach integrates data from diverse sources, including genomics, proteomics, and metabolomics, to predict the toxicological profile of substances in a more accurate and efficient manner. This proactive strategy not only accelerates the identification of promising drug candidates but also aids in the design of safer and more effective therapeutic agents. The integration of predictive toxicology into pharmacological research fosters a more comprehensive understanding of the intricate relationship between drug compounds and biological systems, ultimately leading to improved drug safety profiles and reduced instances of unexpected toxic reactions in clinical settings. As predictive toxicology continues to evolve, its contributions to precision medicine and personalized treatment strategies are becoming increasingly evident, paving the way for a future where pharmaceutical interventions are not only effective but also tailored to individual genetic and physiological profiles.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia